Our study observed a significant rise in IL-8 serum levels among patients experiencing heartburn and/or regurgitation symptoms, who also had objective evidence of GERD in the form of erosive esophagitis, compared to those lacking such evidence. This evidence concerns the gene CXCL8 and gastroesophageal reflux disease.